Hypothesis

Hormetic stressors such as caloric restriction or exercise preserve cholinergic basal forebrain structure by transiently inhibiting anabolic signaling (e.g., mTORC1) and activating catabolic stress pathways (AMPK, HIF‑1α). This state protects neurons from damage but does not engage the molecular machinery required for axonal repair. True repair of NGF retrograde transport and cholinergic varicosity reactivation depends on a recovery phase in which mTORC1 is re‑activated, allowing protein synthesis, mitochondrial biogenesis, and trophic‑factor trafficking. Without such a recovery window, the protective effect collapses once the stressor is removed, revealing that hormesis sustains a threat‑response mode rather than initiating lasting repair.

Mechanistic Basis

1. Stress‑induced AMPK/HIF-1α activation → phosphorylation of TSC2 and REDD1 → suppression of mTORC1 → reduced global translation and axonal growth.
2. Concurrent ROS mitigation → activation of Nrf2 and SOD2 lowers oxidative damage, preserving ChAT activity and varicosity density (see [1][2][3]).
3. Repair requirement → mTORC1‑dependent synthesis of cytoskeletal proteins (e.g., tau, neurofilament), vesicle‑traffic machinery (kinesin‑1, dynein), and NGF‑TrkA complexes is essential for retrograde transport restoration ([4]).
4. Decoupling → hormesis provides step 2 but maintains step 1, blocking step 3; only when stress ceases and nutrients rebound (re‑feeding, post‑exercise rest) does mTORC1 reactivate, permitting repair.

Testable Predictions

• If cholinergic preservation under ho

Hypothesis

During cellular senescence, the gain of H3K27me3 at gene‑rich regions is not a passive consequence of global chromatin loss but is actively driven by a phase‑separated condensate formed between the intrinsically disordered region (IDR) of EZH2 and residual LMNB1 fragments at the nuclear periphery. This condensate concentrates EZH2 activity, enabling localized H3K27me3 deposition despite overall LMNB1 depletion. Disrupting the EZH2‑IDR/LMNB1 interaction should prevent the paradoxical H3K27me3 gain, block senescence‑associated heterochromatic foci (SAHF) formation, and attenuate the senescence‑associated secretory phenotype (SASP) without affecting global LMNB1 levels.

Mechanistic Rationale

• Phase separation as a spatial organizer: Recent work shows that many chromatin modifiers, including EZH2, contain low‑complexity IDRs that promote biomolecular condensates (3). In senescence, LMNB1 depletion from LADs exposes lamin‑associated chromatin, creating a sticky scaffold that can nucleate EZH2 IDR‑dependent droplets.
• Coupling to H3K27me3 activity: Within these droplets, EZH2’s catalytic SET domain is highly concentrated, increasing its effective concentration toward nucleosomes that become transiently accessible as H3K9me3 and H3K27me3 globally retreat from LADs (1). This explains the observed local H3K27me3 gain at gene‑rich sites while the bulk mark declines.
• Link to SAHF and SASP: SAHFs are thought to lock away proliferation‑promoting genes; how

Aged hematopoietic stem cells (HSCs) retain intact JAK2/STAT5 signaling but fail to respond to erythropoietin (EPO) under steady‑state conditions, a deficit that is reversed only by acute threats such as ischemia, fasting‑refeeding, or oxidative challenge [1][2][3]. We hypothesize that this conditional responsiveness stems from a bistable epigenetic switch in which chronic niche‑derived inflammation locks the EpoR promoter in a methylated, transcriptionally silent state via SOCS3‑directed recruitment of DNMT3A, while acute stress triggers HIF‑1α‑mediated recruitment of TET2 to demethylate the same locus, thereby restoring EPO sensitivity without altering basal JAK2/STAT5 protein levels.

Mechanistic reasoning

1. Inflammatory priming – Persistent IL‑6/TNF‑α signaling in the aged marrow niche sustains SOCS3 expression. SOCS3 not only blocks JAK2/STAT5 phosphorylation [1] but also serves as a scaffold that brings DNMT3A to the EpoR promoter CpG island, establishing a repressive methylation mark that hinders transcription factor binding (e.g., GATA‑1, KLF1). This explains why elevated circulating EPO cannot drive erythropoiesis despite normal receptor protein levels.
2. Stress‑induced demethylation – Acute metabolic or hypoxic stress stabilizes HIF‑1α, which interacts with TET2 and recruits it to the EpoR promoter. TET2 oxidizes 5‑methylcytosine, initiating

Acarbose extends lifespan in male mice by fostering a bloom of Muribaculaceae that increases colonic propionate production. Propionate activates hepatic GPR41 (FFAR3), triggering a fibroblast growth factor 21 (FGF21) endocrine response that improves mitochondrial function and suppresses inflammasome activation. Androgen signaling upregulates hepatic GPR41 expression, explaining the stronger effect in males. Therefore, the microbial metabolite propionate is a necessary mediator of acarbose longevity, acting through a GPR41‑FGF21 axis that is potentiated by male sex hormones.

Mechanistic model

1. Carbohydrate maldigestion – Acarbose inhibits intestinal α‑glucosidase, delivering more starch to the distal gut.
2. Microbiota shift – Undigested starch selectively fuels Muribaculaceae, raising luminal propionate ~1.8‑fold.
3. Propionate signaling – Propionate reaches the liver via portal circulation and binds GPR41 on hepatocytes.
4. FGF21 induction – GPR41 activation stimulates a PPARα‑dependent transcriptional program that increases hepatic FGF21 secretion.
5. Systemic effects – FGF21 enhances fatty acid oxidation, improves NAD⁺/NADH redox balance, and inhibits NLRP3 inflammasome activity, thereby reducing oxidative stress and inflammation.
6. Sex dimorphism – Testosterone augments hepatic GPR41 transcription (via androgen response elements), yielding higher FGF21 output in males.
7. Longevity outcome – Improved metabolic homeostasis and reduced inflammasome‑driven damage translate into extended median lifespan.

Testable predictions

• **

Mechanism

The germline protects its genome by coupling epigenetic reset with organelle quality control and proliferative restraint. We propose that a somatic cell can acquire the same protection when three interventions are applied together: (1) a short pulse of OSKM factors to erase age‑related DNA methylation and reactivate telomerase, (2) pharmacological inhibition of mTORC1 (e.g., rapamycin) to trigger BNIP3‑dependent mitophagy, and (3) activation of FOXO transcription factors (via AKT inhibition) to enforce cell‑cycle checkpoints and limit clonal expansion. This triplet mirrors the germline’s use of genome‑wide demethylation, PGM via BNIP3, telomerase activity, and IGF‑1/FOXO‑mediated proliferative flux control.

Prediction

Mice treated with the combined protocol will show a younger epigenetic clock in liver, muscle and brain, increased mtDNA copy number with lower heteroplasmy, and preserved telomere length compared with OSKM‑only or single‑agent controls. Importantly, the incidence of spontaneous tumors over a 2‑year lifespan will not exceed that of untreated age‑matched cohorts, demonstrating that the added mitochondrial and proliferative safeguards prevent the oncogenic risk associated with telomerase activation alone.

Experimental Design

• Animal model: C57BL/6J mice, both sexes, n=30 per group.
• Groups: (A) vehicle control, (B) transient OSKM (doxycycline‑inducible, 2 days on/5 days off, 4 cycles), (C) OSKM + rapamycin (1 mg/kg i.p. three times weekly), (D) OSKM + FOXO activator (e.g., AS1842856, 50 mg/kg oral daily), (E) full triplet (OSKM 

We hypothesize that a brief NAD+ boosting phase before intermittent dasatinib+quercetin (D+Q) treatment aligns G1 and G2 senescent subpopulations, increasing their susceptibility to clearance and breaking the SASP‑CD38‑NAD+ feedback loop.

Rationale

Recent work shows that senescent cells are not uniform; DNA content stratification separates G1 and G2 subpopulations with distinct senolytic sensitivity[6]. Simultaneously, senescent cells drive CD38 expression in neighbors, consuming NAD+ and suppressing AMPK activity[3]. NAD+ replenishment activates AMPK, which inhibits mTORC1, promotes autophagy, and can push cells toward a uniform metabolic state[4]. We propose that a short course of an NAD+ precursor (e.g., nicotinamide riboside) transiently elevates AMPK activity, reduces mTORC1 signaling, and synchronizes the cell‑cycle distribution of senescent cells, making both G1 and G2 cohorts equally accessible to D+Q.

Testable Predictions

1. In aged mice, NAD+ priming for 48 h followed by intermittent D+Q will lower the proportion of G1 and G2 senescent cells more evenly than D+Q alone, as measured by DNA‑content flow cytometry[6].
2. The combined regimen will reduce SASP‑mediated CD38 upregulation in neighboring non‑senescent cells, resulting in higher tissue NAD+ levels compared with D+Q alone[3].
3. Functional readouts (grip

Chronic mTOR inhibition extends lifespan by activating hormetic pathways that resemble ancestral scarcity signals, yet it remains unclear whether this pharmacological state reproduces or opposes the endocrine signature of natural adrenal aging. We hypothesize that rapamycin maintains zona reticularis DHEA production and normalizes the cortisol:DHEA ratio by simultaneously suppressing maladaptive zona glomerulosa activity and enhancing stromal support, thereby creating a compensatory adaptive endocrine state distinct from the high‑cortisol/low‑DHEA profile of adrenopause.

To test this, we will treat middle‑aged male C57BL/6 mice with rapamycin (14 mg/kg diet) or control diet for 6 months. At the end of the treatment we will measure:

1. Plasma corticosterone (mouse cortisol analog) basal levels and stress‑induced response after 15 min restraint (to approximate the cortisol awakening response).
2. Plasma DHEA‑S concentration.
3. Aldosterone levels to assess zona glomerulosa output.
4. Adrenal gland histology: zone thickness (glomerulosa, fasciculata, reticularis), collagen deposition (Sirius Red), and capillary density (CD31 immunostaining).
5. Single‑cell RNA‑seq of adrenal cells to quantify zone‑specific steroidogenic enzyme expression (Cyp11b2, Cyp11b1, Cyp17a1) and stress‑response genes (Atg5, Mapk1/3).

We predict that rapamycin‑treated mice will show:

• No increase in basal corticosterone and a blunted stress‑induced rise relative to controls, indicating preserved HPA feedback.
• Elevated or unchanged DHEA‑S with a significantly lower corticosterone:DHEA‑S ratio compare

Hypothesis

Aging‑associated interactome rewiring begins in the kidney and spleen before detectable changes in bulk protein abundance, and this early rewiring is mediated by sex‑dependent destabilization of chaperone‑rich protein‑protein interaction (PPI) hubs. Loss of these hubs triggers a cascade that overwhelms proteostasis networks, leading to tissue‑specific aging signatures.

Rationale

• Proteomic profiling shows kidney and spleen exhibit the earliest organ‑specific aging changes [1].
• In cognitively healthy centenarians, proteins such as FHL1, EZR, CRK, CAP2, and PHACTR1—many of which act as signaling or cytoskeletal hubs—are preserved, suggesting hub stability correlates with resilience [2].
• Evolutionary conservation of longevity‑associated PPI networks links invertebrate longevity genes to human muscle expression patterns [3], indicating that certain hubs are functionally important across species.
• Proteostasis decline is a recognized hallmark of aging [4]; however, the temporal order between interactome perturbation and proteostatic failure remains unclear.

We propose that specific PPI hubs enriched for cochaperones (e.g., HSP90AA1, HSP70, and their co‑chaperones) are disproportionately vulnerable in kidney and spleen. Their disruption occurs early, before substantial changes in the steady‑state levels of the hub proteins themselves, and exhibits marked sex differences due to hormonal regulation of chaperone expression and activity.

Predictions

1. Early PPI loss: In young adult mice (3 months), affinity purification coupled with mass spectrometry

Hypothesis

Mechanistic basis

Aging thymus shows NLRP3 inflammasome activation driven by lipid overload, leading to caspase‑1 cleavage, IL‑1β/IL‑18 release, and suppression of IL‑7 in thymic epithelial cells (TECs)1. Concurrently, elevated IL‑6 promotes trans‑signaling via soluble IL‑6R (sIL‑6R), activating STAT3 in stromal and hematopoietic cells, which induces SOCS3 that blunts IL‑7‑mediated Bcl‑2 expression in naïve T cells2. We propose that IL‑1β released from NLRP3‑active macrophages and dendritic cells upregulates sIL‑6R production, amplifying IL‑6 trans‑signaling and creating a feedforward loop that sustains inflammasome activation and STAT3 signaling in the thymic niche.

Prediction

Combined pharmacological inhibition of NLRP3 (using MCC950) and selective blockade of IL‑6 trans‑signaling (using sgp130Fc, an inhibitor of the IL‑6/sIL‑6R complex) will produce synergistic restoration of thymic architecture, increased output of naïve T cells, and improved peripheral immune competence beyond that achieved by either monotherapy.

Experimental design

• Animals: 20‑month‑old C57BL/6 mice (n=10 per group).
• Groups: (1) Vehicle control; (2) MCC950 alone (50 mg/kg i.p. thrice weekly); (3) sgp130Fc alone (10 mg/kg i.p. twice weekly); (4) Combination MCC950 + sgp130Fc at same doses.
• Duration: 8 weeks.
• Readouts:

Hypothesis Timed inhibition of mTORC1 during the fasting phase restores its ability to oscillate between fed and fasted states in aged duodenal L-cells, thereby rescuing nutrient‑responsive GLP-1 secretion and improving systemic glucose homeostasis.

Mechanistic Rationale Aging locks mTORC1 in a constitutively high, nutrient‑insensitive state [1][4], which impairs the cyclic synthesis of nutrient‑sensing GPCRs and transporters needed for L‑cell activation [2]. Simultaneously, the lack of a fasting‑phase dip suppresses autophagy‑mediated quality control of secretory vesicles and mitochondria [3], leading to depleted GLP-1 stores and vesicular trafficking defects. Because mTORC1 activity also drives transcription factors such as TFEB that coordinate lysosomal biogenesis, its loss of dynamism disrupts the coupling between nutrient influx and secretory replenishment. The result is a ‘stuck dial’ where L‑cells cannot up‑receptorial machinery during meals nor clear damaged components during rest, producing a secretory exhaustion phenotype.

We propose that brief, circadian‑aligned rapamycin exposure—delivered during the early fasting window—creates a transient mTORC1 trough that permits autophagy flux and resets the signaling circuit. When nutrients reappear, mTORC1 reactivates, driving de novo synthesis of GLP-1 secretory machinery (e.g., SGLT1, FFAR2, CaSR) and refilling vesicles. This restores the physiological feed‑fast cycle that young L‑cells naturally exhibit.

Predictions

1. Aged mice receiving intermittent rapamycin synchronized with the dark‑phase fasting pe

Hypothesis

Senescent cells deliberately tune lysosomal membrane permeabilization to release cathepsins at sub‑lethal concentrations, converting lysosomal damage into a graded chemokine‑like signal that recruits and activates immune cells without triggering apoptosis.

Mechanistic Basis

Low‑level LMP permits limited cathepsin B and L efflux into the cytosol LMP enables graded cathepsin release. Cytosolic cathepsins cleave specific substrates that amplify danger signaling: they process pro‑IL‑1β and pro‑IL‑18 for NLRP3 inflammasome activation Cathepsins B and L support NLRP3 inflammasome assembly and, independently of the inflammasome, drive IL‑1β secretion through cathepsin‑sensitive pathways Particle-induced IL-1β secretion is cathepsin-sensitive. The decline of cystatin B (CSTB) removes endogenous inhibition, raising cathepsin activity just enough to sustain histone H3 tail cleavage and senescence‑associated chromatin changes CSTB deficiency sustains histone H3 tail cleavage while elevating cathepsin B in disomic contexts CSTB reduction elevates cathepsin B activity. In aging brain, cathepsin D, E and B rise, providing a reservoir that can be mobilized via LMP [Cathepsin levels increase with age](htt

Hypothesis

Transient senescent fibroblasts secrete a matrix‑anchored latent TGF‑β1 isoform that remains sequestered in the extracellular matrix until mechanical strain triggers its activation, thereby acting as a temporary brake on fibroblast‑to‑myofibroblast conversion during the early phase of wound repair. With prolonged senescence, MMP‑14 (MT1‑MMP) cleaves the latent TGF‑β binding protein (LTBP‑1) within the SASP, liberating soluble TGF‑β1 and converting the secretome into a pro‑fibrotic signal that sustains myofibroblast activity and matrix deposition.

Core Mechanistic Insight

• The matrix‑bound isoform is characterized by a covalently linked LTBP‑1‑TGF‑β1 complex that resists proteolysis and requires integrin‑αVβ3‑mediated tensile force for release.
• MMP‑14 preferentially cleaves the hinge region of LTBP‑1, a modification absent in the transient SASP but enriched in chronic senescent fibroblasts.
• Loss of the anchored complex shifts TGF‑β signaling from a transient, context‑dependent pulse to a sustained, autocrine loop that drives SMAD2/3‑dependent transcription of COL1A1 and ACTA2.

Testable Predictions

1. In young mice subjected to a full‑thickness dermal wound, fibroblast‑specific Mmp14 knockout will retain higher levels of matrix‑bound TGF‑β1 (measured after acid‑soluble extraction) and display reduced α‑SMA+ myofibroblast density at day 5 post‑injury, without altering senescent cell frequency as assessed by p16^Ink4a^ reporter.
2. Early (0‑48 h) intermittent navitoclax treatment in wild‑type wounded mice will deplete the nascent senescent fibrobla

Hypothesis

Age-related senescence of choroid plexus epithelial cells (CPECs) initiates a localized senescence-associated secretory phenotype (SASP) that suppresses secreted α-Klotho transcription before measurable declines in circulating Klotho or rises in FGF23. This early brain‑specific Klotho loss disrupts cerebrospinal fluid (CSF) Klotho‑FGF23 signaling, leading to central FGF23 resistance that subsequently drives systemic phosphate dysregulation and multi‑organ aging.

Mechanistic Rationale

1. CPEC Senescence and SASP – CPECs exhibit heightened p16^INK4a^ and γH2AX signaling with age, secreting IL‑6, IL-1β, and TGF‑β1 (8). SASP factors are known to inhibit Klotho promoter activity via SMAD3‑dependent repression and NF‑κB‑mediated chromatin remodeling (3).
2. CSF Klotho as a Gatekeeper – Secreted Klotho in CSF acts as a high‑affinity FGF23 co‑factor that modulates FGFR1 signaling in hypothalamic nuclei controlling renal phosphate handling (4). Loss of CSF Klotho reduces FGF23‑dependent ERK phosphorylation in these centers, creating a central resistance state that blunts phosphaturic responses despite normal or elevated FGF23.
3. Feed‑Forward Loop – Central FGF23 resistance elevates serum FGF23 as a compensatory attempt to promote phosphaturia, but peripheral Klotho deficiency (especially in kidney) prevents effective signaling, resulting in hyperphosphatemia, VEGF‑driven

Hypothesis

Morning bright light entrains the suprachiasmatic nucleus (SCN) to increase sympathetic outflow to the gut and liver, which suppresses phenylalanine‑ammonia‑lyase (PAL) activity in colonic bacteria and reduces hepatic conversion of phenylalanine to phenylacetic acid (PAA). Lower circulating PAA prevents endothelial cell senescence, thereby breaking the brain→gut→vascular aging loop and extending healthspan.

Mechanistic Rationale

• The SCN drives a diurnal rhythm of sympathetic norepinephrine release that directly influences intestinal epithelial permeability and microbial gene expression (3).
• Norepinephrine signaling downregulates bacterial PAL enzymes through β‑adrenergic receptors on enterochromaffin cells, decreasing microbial production of phenylalanine derivatives that are absorbed and hepaticly oxidized to PAA (6).
• PAA circulates to the vasculature where it induces endothelial senescence via DNA‑damage‑associated secretory phenotype (SASP) markers (p16^INK4a, SA‑β‑gal) (6).
• Senescent endothelial cells exacerbate inflammaging and impair nitric‑oxide‑mediated vasodilation, accelerating arterial stiffness and cognitive decline.
• Thus, enhancing SCN‑sympathetic tone with timed morning light should lower PAA, preserve endothelial function, and improve both metabolic and neurocognitive outcomes.

Testable Predictions

1. In aged mice, daily 30‑minute exposure to

Hypothesis

Aged B cells, driven by chronic BCR signaling and insulin receptor activation, release excess extracellular vesicles (EVs) enriched in specific microRNAs that impair T follicular helper (Tfh) cell differentiation and function. This EV-mediated suppression explains the observed Tfh precursor accumulation without functional maturation and offers a testable point of intervention.

Mechanistic Basis

• Constitutive BCR signaling in aged B cells elevates Syk, Btk, PLCγ2, and Akt phosphorylation 3.
• Insulin receptor signaling in these B cells further augments Akt activity, promoting Rab27a-dependent EV secretion (novel link).
• Aged B-cell EVs are enriched for miR-155 and miR-146a, miRNAs known to target metabolic regulators such as mTOR and HIF1alpha, thereby blunting the glycolytic shift required for Tfh maturation.
• Naive CD4+ T cells internalizing these EVs show reduced CXCR5 and Bcl6 expression, impaired CD40L and IL-21 production, and a persistence of RBPj-high precursors, matching the phenotype described in aged Tfh cells 4 and 5.

Experimental Plan

1. EV isolation – Purify EVs from spleen B cells of young (3 mo) and aged (24 mo) mice using ultracentrifugation or size-exclusion chromatography. Quantify miR-155/miR-146a by qRT-PCR.
2. In vitro Tfh polarization – Culture naive CD4+ T cells with anti-CD3/CD28, IL-6, and IL-21 in the presence of young or aged B-cell EVs. Assess Tfh markers (CXCR5, PD-1,

Hypothesis

Continuous mTOR inhibition (e.g., chronic rapamycin) fails to repair the aging gut barrier because it simultaneously blocks the regenerative intestinal stem cell (ISC) expansion required for epithelial renewal. We hypothesize that intermittent, circadian‑aligned pulses of mTOR inhibition will improve tight junction (TJ) structure and reduce systemic inflammaging by allowing two complementary phases: (1) an inhibition window that activates autophagy‑mediated clearance of damaged TJ proteins, and (2) a refeeding window that permits mTORC1‑driven ISC proliferation and differentiation to replace lost epithelium.

Mechanistic Rationale

1. Autophagic removal of compromised TJ complexes – mTORC1 suppresses autophagy; its inhibition triggers LC3‑dependent engulfment of ubiquitinated occludin, ZO‑1, and claudin‑2, facilitating their degradation and preventing the accumulation of leak‑prone pores (3).
2. ISC dependence on mTORC1 activity – Intestinal stem cells require transient mTORC1 activation for protein synthesis, metabolic reprogramming, and clonal expansion during injury or homeostatic turnover (5). Chronic rapamycin abolishes this proliferative burst, leading to epithelial atrophy despite reduced inflammation.
3. Feedback between barrier repair and inflammaging – Restored TJ integrity limits bacterial endotoxin translocation, lowering TLR4‑NF‑κB signaling and consequently decreasing miR‑191‑5p upregulation and CB₁‑driven cytokine loops ([

Hypothesis

Combining morning bright light exposure (≥10,000 lux, 30 min upon waking), evening blue‑light blocking glasses (446‑483 nm) from sunset to bedtime, and an early time‑restricted eating window (8 am–4 pm) will act synergistically to raise nocturnal hepatic NAD+ levels, enhance SIRT1 deacetylase activity, and thereby amplify the amplitude of core circadian clock genes (BMAL1, CLOCK, PER2) in humans.

Mechanistic Rationale

1. Melatonin suppression by evening blue light reduces NAMPT transcription, limiting the NAD+ salvage pathway and lowering SIRT1 activity【1†https://pubmed.ncbi.nlm.nih.gov/23509952/】.
2. Morning bright light advances the cortisol awakening response and stimulates AMPK, which increases NAMPT expression and NAD+ synthesis【7†https://medicalxpress.com/news/2025-09-americans-healthier-permanent-standard.html】.
3. Early time‑restricted eating aligns nutrient‑sensing pathways (mTORC1 inhibition, AMPK activation) with the endogenous NAD+ oscillation peak that occurs during the early active phase【5†https://www.utsouthwestern.edu/newsroom/articles/year-2022/active-phase-calorie-restriction.html】.
4. Elevated NAD+ fuels SIRT1‑mediated deacetylation of BMAL1 and PER2, strengthening transcriptional feedback loops and increasing the robustness of circadian rhythms【2†https://www.chronobiologyinmedicine.org/m/journal/view.php?number=167】.
5. Stronger circadian rhythms improve sleep architecture, particularly frontal slow‑wave activity, reducing metabolic inflammation and delaying age‑related decline【3†https://www.frontiersin.org/journals/aging/articles/10.

Hypothesis

The cyclic GMP‑AMP synthase–STING (cGAS‑STING) DNA‑sensing pathway functions as an upstream coordinator that links primary aging insults—genomic instability, epigenetic drift, and mitochondrial dysfunction—to downstream antagonistic responses and integrative failures, thereby driving the coordinated emergence of the hallmarks of aging.

Mechanistic Rationale

• cGAS detects cytosolic DNA arising from nuclear chromatin leakage (epigenetic drift/genomic instability) and mitochondrial DNA release (mitochondrial dysfunction) [2, 3].
• Activated cGAS synthesizes 2'3'-cGAMP, which binds STING on the endoplasmic reticulum, triggering TBK1‑IRF3 signaling and, crucially, activating the NF‑κB pathway [5].
• Chronic STING signaling sustains NF‑κB/NLRP3 inflammasome activity, promoting sterile inflammation (inflammaging) and reinforcing a feedback loop where NF‑κB primes NLRP3 while p62/SQSTM1‑mediated mitophagy attempts to limit mtDNA release [3].
• Persistent STING‑NF‑κB signaling drives senescence-associated secretory phenotype (SASP) secretion, exacerbates stem cell exhaustion via inflammatory niche alteration, and disrupts intercellular communication, aligning with integrative hallmarks [1, 6].
• This places cGAS‑STING at a nexus where primary damages converge, amplifying antagonist

Hypothesis: In aged cells, the combined action of mTORC1 hyperactivity, Rubicon accumulation, and p300‑mediated VPS34 acetylation raises the autophagic activation threshold, making short fasts insufficient to initiate flux. Restoring NAD+ levels activates SIRT1, which deacetylates TFEB and VPS34, thereby lowering mTORC1‑dependent inhibition and counteracting p300‑VPS34 interference. This dual action predicts that NAD+ boosting will shorten the fasting period required to achieve autophagic flux comparable to that seen in young animals under 16:8 regimens.

Testable Predictions

1. Biochemical – In liver from 24‑month‑old mice, a 16‑hour fast combined with nicotinamide riboside (NR) will increase nuclear TFEB, decrease VPS34 acetylation (measured by immunoprecipitation‑Western), and elevate LC3‑II turnover (with bafilomycin A1) to levels matching those of young mice after a 16‑hour fast alone.
2. Functional – The same NR‑plus‑16h fast condition will reduce p62/SQSTM1 accumulation and increase lysosomal glucosylceramide hydrolase activity, indicating restored autophagosome‑lysosome coupling.
3. Dose‑response – NR alone will not significantly alter flux; low‑dose rapamycin (mTORC1 inhibitor) plus NR will produce additive effects, whereas rapamycin alone will require a longer fast (≥20 h) to reach comparable flux.
4. Genetic validation – Liver‑specific SIRT1 knockout mice will fail to show the NR‑induced reduction in fasting threshold, confirming SIRT1 dependence.

Experimental Design

• Animals: Young (3 mo) and aged (24 mo) C57BL/6 mice; SIRT1 liver